Cargando…
m(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A/PD-L1 manner
Emerging evidence indicates the critical roles of N(6)-methyladenosine (m(6)A) modification in human cancers. Herein, our work reported that a novel m(6)A-modified circRNA from the MYO1C gene, circMYO1C, upregulated in the pancreatic ductal adenocarcinoma (PDAC). Our findings demonstrated that circM...
Autores principales: | Guan, Hua, Tian, Kun, Luo, Wei, Li, Mingfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925427/ https://www.ncbi.nlm.nih.gov/pubmed/36781839 http://dx.doi.org/10.1038/s41419-023-05570-0 |
Ejemplares similares
-
Crosstalk between m6A mRNAs and m6A circRNAs and the time-specific biogenesis of m6A circRNAs after OGD/R in primary neurons
por: Zhang, Chi, et al.
Publicado: (2023) -
The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020) -
m(6)A-modified circRNAs: detections, mechanisms, and prospects in cancers
por: Qin, Shiyi, et al.
Publicado: (2022) -
Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma
por: Wang, Jiayi, et al.
Publicado: (2023) -
Differential methylation of circRNA m6A in an APP/PS1 Alzheimer's disease mouse model
por: Zhang, Xiao, et al.
Publicado: (2023)